539 results
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
to be an independent Director in accordance with any national securities exchange on which the corporation’s securities are listed.
(c) A candidate … , independent accountants or other persons as to matters which the Director or executive officer believed to be within such person's professional
S-8
EX-23.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
1 Mar 24
Registration of securities for employees
4:09pm
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement
S-8
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
1 Mar 24
Registration of securities for employees
4:09pm
& Watkins LLP
2022 Employment Inducement Plan
10-Q
Amendment to the 2022 Employment Inducement Plan
Consent of Ernst & Young LLP, independent registered
8-K
EX-10.1
l4oyw1bhhsdh5an
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
iuuujo1w7zw00e0
27 Sep 23
Departure of Directors or Certain Officers
8:38am
8-K
2evgb1 pvadsb3t
9 Jun 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
EX-99.1
rmwyc0iakbz1lnl
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
8-K
EX-10.1
0cmmt cvmb67wf
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm